Abstract:Myocardial ischemia is a leading cause of death all over the world. The most effective way to salvage ischemic myocardium is the restoration of blood flow, but reperfusion itself may cause additional tissue injury called “ischemia/reperfusion injury (I/RI)”. Activation of cell apoptosis is a major form of cell death during myocardial I/RI. Thus, examining ways to control cell apoptosis has important clinical significance for improving post‐ischemic recovery. MicroRNAs (miR), small non‐coding RNA molecules that regulate gene expression by inhibiting mRNA translation and/or inducing mRNA degradation, play a crucial role in various cellular and biological processes. The clinical evidence demonstrated that miR‐181c was significantly up‐regulated in the early phase of myocardial infarction. However, whether or not miR‐181c mediates cardiac I/RI through cell apoptosis pathway is unknown. Thus, the present study aimed to investigate the role of miR‐181c in hypoxia/reoxygenation (H/R, 6 hours hypoxia followed by6 hours reoxygenation) induced cell injury in H9C2 cardiomyocytes and its possible mechanism. The results showed that H/R significantly increased the expression of miR‐181c‐5p (P<0.05 vs. Control) but not miR‐181c‐3p in H9C2 cells. In line with this, in an in vivo rat cardiac I/RI model (30 min left anterior descending coronary artery ligation followed by 2 hours reperfusion), miR‐181c‐5p expression was also significantly increased (P<0.05 vs. Control), suggesting that miR‐181c‐5p may be involved in the pathogenesis of cardiac I/RI. Under the experimental setting, H/R significantly induced H9C2 cells injury, as evidenced by increased lactic acid dehydrogenase (LDH) leakage (cell injury marker, P<0.05 vs. Control) and reduced cell viability (MTT assay, P<0.05 vs. Control). Furthermore, H/R‐induced cell injury was accompanied by increased cleaved caspase‐3 expression and more TUNEL positive cells (markers of cell apoptosis, P<0.05 vs. Control), but no significant changes in the expression of Bcl‐2 (anti‐apoptotic) and Bax (pro‐apoptotic), suggesting that H/R induces caspase‐3 dependent cell apoptosis, which was independent of the intrinsic mitochondrial pathway. To demonstrate the potential role of miR‐181c‐5p in H/R‐induced cell injury, H9C2 cells were transfected with the miR‐181c‐5pagomir or its negative control. The overexpression of miR‐181c‐5psignificantly aggravated H/R‐induced cell injury (increased LDH level and reduced cell viability, P<0.05 vs.H/R) and exacerbated H/R‐induced cell apoptosis (greater cleaved caspases‐3 expression and more TUNEL positive cells, P<0.05 vs.H/R). In contrast, in H9C2 cells transfected with miR‐181c‐5p antagomir, inhibition of miR‐181c‐5p significantly suppressed H/R‐induced enhancement of LDH level and cleaved caspase‐3 expression and apoptotic cell death(P<0.05 vs.H/R). It is concluded that in H9C2 cells, H/R may induce cardiomyocytes apoptosis via enhanced miR‐181c‐5p expression, which may yield novel strategies to combat myocardial I/RI.Support or Funding InformationThe authors' research was supported by General Research Fund (17158616M and 17124614M, Research Grants Council of Hong Kong).This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Inhibition of microRNA-181a-5p Protects H9c2 Cells from Hypoxia-Induced Injury Through Up-Regulating Sirtuin 1 Expression

Retracted: MicroRNA‐132 Protects H9c2 Cells Against Oxygen and Glucose Deprivation‐evoked Injury by Targeting FOXO3A

Microrna-182-5p Protects H9c2 Cardiomyocytes From Hypoxia-Induced Apoptosis By Down-Regulation Of Pten

MiR-138-5p exacerbates hypoxia/reperfusion-induced heart injury through the inactivation of SIRT1-PGC-1α

MiR-421 Inhibition Protects H9c2 Cells Against Hypoxia/reoxygenation-Induced Oxidative Stress and Apoptosis by Targeting Sirt3

MiR-129-5p Protects Against Myocardial Ischemia-Reperfusion Injury Via Targeting HMGB1

Suppression of microRNA-142-5p attenuates hypoxia-induced apoptosis through targeting SIRT7.

MicroRNA-494 suppresses hypoxia/reoxygenation-induced cardiomyocyte apoptosis and autophagy via the PI3K/AKT/mTOR signaling pathway by targeting SIRT1

The Modulation Effects of Lipopolysaccharide on Mir-211/Siert1 to Enhance Cardiomyocytes Apoptosis Induced by Hypoxia

Inhibition of Microrna-1 Attenuates Hypoxia/re-Oxygenation-induced Apoptosis of Cardiomyocytes by Directly Targeting Bcl-2 but Not GADD45Beta.

Mir-361-3p Mitigates Hypoxia-Induced Cardiomyocyte Injury Via Targeting Apoptosis Initiators Caspase-2 /- 8 /- 9

MicroRNA‐181c‐5p Exacerbates Apoptotic Cell Death in H9C2 Cardiomyocytes During Hypoxia/reoxygenation

Mir-370 Inhibits the Oxidative Stress and Apoptosis of Cardiac Myocytes Induced by Hydrogen Peroxide by Targeting FOXO1.

MicroRNA-9 facilitates hypoxia-induced injury and apoptosis in H9c2 cells via targeting CDK8

Upregulation of Microrna-34A Enhances Myocardial Ischemia-Reperfusion Injury Via the Mitochondrial Apoptotic Pathway

MicroRNA-15a Inhibition Protects Against Hypoxia/reoxygenation-Induced Apoptosis of Cardiomyocytes by Targeting Mothers Against Decapentaplegic Homolog 7

Downregulation of miR‐34c‐5p alleviates chronic intermittent hypoxia‐induced myocardial damage by targeting sirtuin 1

Therapeutic Hypothermia Inhibits Hypoxia‐Induced Cardiomyocyte Apoptosis Via the MiR‐483‐3p/Cdk9 Axis

Inhibition of Mir-322-5p Protects Cardiac Myoblast Cells Against Hypoxia-Induced Apoptosis and Injury Through Regulating CIAPIN1.

MicroRNA-7b attenuates ischemia/reperfusion-induced H9C2 cardiomyocyte apoptosis via the hypoxia inducible factor-1/p-p38 pathway.

Effects of miR-181a targeting XIAP gene on apoptosis of cardiomyocytes induced by hypoxia/reoxygenation and its mechanism.